Isolation and Characterization of Tetracycline-Resistant Clinical Isolates of Helicobacter pylori
Tetracycline is an important component of combination therapies for Helicobacter pylori eradication. Twenty-nine tetracycline-resistant isolates requiring MICs ranging from 4 to 16 μg/ml were isolated from Korean (22 of 460) and Japanese (7 of 105) patients. Interestingly, all of the 29 tetracycline...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
2000
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC101634/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11036054/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.11.3203-3205.2000 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
